What does IMPLANTOPARO do?

IMPLANTOPARO is a dental practice in Gent. Private Limited, started on 16 January 2018, 2 establishments.

What is the address of IMPLANTOPARO?

The registered office of IMPLANTOPARO is located at Sint-Gerolfstraat 33, 9031 Gent.

Is IMPLANTOPARO still active?

Yes. According to the CBE (2 November 2026) IMPLANTOPARO is active, legal situation “Normale toestand”, started on 16 January 2018.

Is IMPLANTOPARO registered on Peppol?

Yes, IMPLANTOPARO is registered on the Peppol network with ID 0208:0688531239.

What is the enterprise number of IMPLANTOPARO?

The enterprise number of IMPLANTOPARO is BE0688531239.

When was IMPLANTOPARO founded?

IMPLANTOPARO was founded on 16 January 2018.

Who are the directors of IMPLANTOPARO?

According to the 2025 annual accounts, the directors of IMPLANTOPARO are: Faris Younes, Siska De Muynck.

Is IMPLANTOPARO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 January 2018; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did IMPLANTOPARO make in 2025?

IMPLANTOPARO posted a profit after taxes of € 192,143 in financial year 2025.

What is the revenue of IMPLANTOPARO?

As a small company, IMPLANTOPARO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 496,636.

How much does an employee at IMPLANTOPARO earn?

The average wage cost per full-time employee at IMPLANTOPARO was € 47,000 in 2025: staff costs of € 65,791 for 1.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does IMPLANTOPARO have?

According to the 2025 annual accounts, IMPLANTOPARO has 1.4 full-time equivalents (FTE).

IMPLANTOPARO (Private Limited) - Gent - BE0688531239

Dossier IMPLANTOPARO, printed on 2 November 2026 from databakkes.be/en/0688531239/implantoparo. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

IMPLANTOPARO from Gent, company number BE0688531239, closed financial year 2025 with a result of € 192,143 after tax. For that financial year IMPLANTOPARO recorded a gross margin of € 496,636 and equity of € 533,228. Compared with financial year 2024, the result moved from € 129,919 to € 192,143. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Healthy

€ 533,228

▼ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 192,143

▲ 48% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 329,471

▼ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 290,119 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

1.4

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 65,791

▲ 5% vs 2024

€ 47,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 153,931

▼ 18% vs 2024

Of which on lease € 110,392.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 731,770

▼ 13% vs 2024

€ 91,330 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 24,442

▼ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 51,803

▲ 77% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 306,643 Gross margin 2022: € 306,643 First fiscal year in the series	€ 252,676 Gross margin 2023: € 252,676 ▼ 18% vs 2022 (€ 306,643) Unfavourable step	€ 390,123 Gross margin 2024: € 390,123 ▲ 54% vs 2023 (€ 252,676) Favourable step	€ 496,636 Gross margin 2025: € 496,636 ▲ 27% vs 2024 (€ 390,123) Favourable step	▲ 27%
Profit after taxes	€ 131,237 Profit after taxes 2022: € 131,237 First fiscal year in the series	€ 61,328 Profit after taxes 2023: € 61,328 ▼ 53% vs 2022 (€ 131,237) Unfavourable step	€ 129,919 Profit after taxes 2024: € 129,919 ▲ 112% vs 2023 (€ 61,328) Favourable step	€ 192,143 Profit after taxes 2025: € 192,143 ▲ 48% vs 2024 (€ 129,919) Favourable step	▲ 48%
Equity	€ 510,213 Equity 2022: € 510,213 First fiscal year in the series	€ 571,542 Equity 2023: € 571,542 ▲ 12% vs 2022 (€ 510,213) Favourable step	€ 631,203 Equity 2024: € 631,203 ▲ 10% vs 2023 (€ 571,542) Favourable step	€ 533,228 Equity 2025: € 533,228 ▼ 16% vs 2024 (€ 631,203) Unfavourable step	▼ 16%
Total debts	€ 591,403 Total debts 2022: € 591,403 First fiscal year in the series	€ 933,933 Total debts 2023: € 933,933 ▲ 58% vs 2022 (€ 591,403) Unfavourable step	€ 908,485 Total debts 2024: € 908,485 ▼ 3% vs 2023 (€ 933,933) Favourable step	€ 808,015 Total debts 2025: € 808,015 ▼ 11% vs 2024 (€ 908,485) Favourable step	▼ 11%
Cash	€ 351,645 Cash 2022: € 351,645 First fiscal year in the series	€ 340,710 Cash 2023: € 340,710 ▼ 3% vs 2022 (€ 351,645) Unfavourable step	€ 438,590 Cash 2024: € 438,590 ▲ 29% vs 2023 (€ 340,710) Favourable step	€ 329,471 Cash 2025: € 329,471 ▼ 25% vs 2024 (€ 438,590) Unfavourable step	▼ 25%
Land & buildings	€ 476,973 Land & buildings 2022: € 476,973 First fiscal year in the series	€ 727,560 Land & buildings 2023: € 727,560 ▲ 53% vs 2022 (€ 476,973) Unchanged	€ 698,735 Land & buildings 2024: € 698,735 ▼ 4% vs 2023 (€ 727,560) Unchanged	€ 689,937 Land & buildings 2025: € 689,937 ▼ 1% vs 2024 (€ 698,735) Unchanged	▼ 1%
Retained profit	€ 497,813 Retained profit 2022: € 497,813 First fiscal year in the series	€ 559,142 Retained profit 2023: € 559,142 ▲ 12% vs 2022 (€ 497,813) Favourable step	€ 612,603 Retained profit 2024: € 612,603 ▲ 10% vs 2023 (€ 559,142) Favourable step	€ 514,628 Retained profit 2025: € 514,628 ▼ 16% vs 2024 (€ 612,603) Unfavourable step	▼ 16%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 76,458 Dividend 2024: € 76,458 Unchanged (€ 0) Unchanged	€ 290,119 Dividend 2025: € 290,119 ▲ 279% vs 2024 (€ 76,458) Unchanged	▲ 279%
Bank debt	€ 537,997 Bank debt 2022: € 537,997 First fiscal year in the series	€ 915,934 Bank debt 2023: € 915,934 ▲ 70% vs 2022 (€ 537,997) Unfavourable step	€ 842,049 Bank debt 2024: € 842,049 ▼ 8% vs 2023 (€ 915,934) Favourable step	€ 731,770 Bank debt 2025: € 731,770 ▼ 13% vs 2024 (€ 842,049) Favourable step	▼ 13%
Balance sheet total	€ 1,101,616 Balance sheet total 2022: € 1,101,616 First fiscal year in the series	€ 1,505,474 Balance sheet total 2023: € 1,505,474 ▲ 37% vs 2022 (€ 1,101,616) Unchanged	€ 1,539,688 Balance sheet total 2024: € 1,539,688 ▲ 2% vs 2023 (€ 1,505,474) Unchanged	€ 1,341,243 Balance sheet total 2025: € 1,341,243 ▼ 13% vs 2024 (€ 1,539,688) Unchanged	▼ 13%
Employees (FTE)	-	-	-	1.4 Employees (FTE) 2025: 1.4 First fiscal year in the series

Key figures of IMPLANTOPARO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to IMPLANTOPARO?

What happened at IMPLANTOPARO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 192,143 (▲ 48% vs 2024). Source: NBB ↗
2024 Siska De Muynck became a director. NBB
Apr 5, 2023 New establishment in Roeselare. KBO
2018 Faris Younes became a director. NBB
Jan 16, 2018 New establishment in Gent. KBO
Jan 16, 2018 Start of the company according to the CBE. KBO

In short

From € 131,237 profit in 2022 to € 192,143 profit in 2025.

Paid € 210,678 in corporate taxes since 2022.

Best year ever: 2025, with € 192,143 profit.

On average € 354,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Faris Younes Siska De Muynck

IMPLANTOPARO

Behind IMPLANTOPARO are Faris Younes and Siska De Muynck.

Directors

According to the 2025 annual accounts

Faris Younes

Director

since 2018

Siska De Muynck

Director

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Gerolfstraat 33

9031 Gent

2.343.460.711

Izegemsestraat 12

8800 Roeselare

Active since 5 April 2023

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0688.531.239
VAT number: BE 0688.531.239
Registered office: Sint-Gerolfstraat 33, 9031 Gent
Names & denominations: IMPLANTOPARO
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 January 2018
Peppol: Active · Active since 13 May 2025
Activities · NACE: Activiteiten van tandartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗